<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Most of the studies, especially those based on humans, which serve to determine the bioavailability of omega-3 acids, apply to their oral administration. It is difficult to fully validate the parenteral administration of omega-3 fatty acids in relation to the healthy population, because this method of supply is reserved mainly for patients undergoing intensive therapy, both adults and preterm infants [
 <xref rid="B142-nutrients-10-01662" ref-type="bibr" class="xref">142</xref>,
 <xref rid="B192-nutrients-10-01662" ref-type="bibr" class="xref">192</xref>,
 <xref rid="B193-nutrients-10-01662" ref-type="bibr" class="xref">193</xref>]. In addition, it is worth noting that parenteral administration of mixtures based on fish oil may lead to biochemical liver damage and even the progression of fibrosis in this organ [
 <xref rid="B194-nutrients-10-01662" ref-type="bibr" class="xref">194</xref>].
</p>
